Literature DB >> 22841187

Donation after cardiac death: where, when, and how?

R Ciria1, J Briceno, S Rufian, A Luque, P Lopez-Cillero.   

Abstract

The continuing shortage of donors has led to the increasing use of marginal grafts. Surgical techniques such as split, domino, and living donations have not been able to decrease waiting list mortality. Donation after cardiac death (DCD) was the only source of grafts prior to the establishment of brain death criteria in 1968. Thereafter, donation after brain death emerged as the leading source of grafts. The context in which irreversible cessation of circulatory and respiratory functions happens was the cornerstone to definite the four categories of DCD by the First International Workshop on DCD held in Maastricht in 1995. Controlled (CDCD) and uncontrolled (UDCD) categories now account for 10%-20% of the donor pool in several countries. Despite initial high rates of primary nonfunction and ischemic-type biliary lesions, refinements in protocols and surgical techniques have led to excellent 1- and 3-year graft survivals of 80% and 70%, respectively with PNF and ITBL rates below 3%. The institution of UDCD and CDCD depends on legal considerations of presumed consent and withdrawal of maneuvers, respectively. The potential for DCD programs is huge; it may be the only real, effective way to increase the grafts pool, both in adult and pediatric populations. Recent advances in perfusion machines will surely optimize this donor pool and allow new therapies for graft resuscitation.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22841187     DOI: 10.1016/j.transproceed.2012.05.003

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  3 in total

Review 1.  Philosophy of organ donation: Review of ethical facets.

Authors:  Aparna R Dalal
Journal:  World J Transplant       Date:  2015-06-24

2.  Liver transplantation using the otherwise-discarded partial liver resection graft with hepatic benign tumor: Analysis of a preliminary experience on 15 consecutive cases.

Authors:  Guoqiang Li; Xiaoxin Mu; Xinli Huang; Xiaofeng Qian; Jianjie Qin; Zhongming Tan; Wenjie Zhang; Xiaoliang Xu; Shanbai Tan; Zhijun Zhu; Wei Li; Xuan Wang; Xuehao Wang; Beicheng Sun
Journal:  Medicine (Baltimore)       Date:  2017-07       Impact factor: 1.889

3.  Clinical Analysis of Classification and Prognosis of Ischemia-Type Biliary Lesions After Liver Transplantation.

Authors:  Rui Shi; Tong Liu; Zirong Liu; Yamin Zhang; Zhongyang Shen
Journal:  Ann Transplant       Date:  2018-03-20       Impact factor: 1.530

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.